Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world, causing ~1.5 million deaths every year. The World Health Organization initiated an End TB Strategy that aims to reduce TB-related deaths in 2035 by 95%. Recent research goals have focused on discovering more eff...
Հիմնական հեղինակներ: | , , , , , , , , , , , , , , , , |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
Public Library of Science (PLoS)
2023-06-01
|
Շարք: | PLoS Computational Biology |
Առցանց հասանելիություն: | https://doi.org/10.1371/journal.pcbi.1010823 |